wehewehe
ʻO Vorolazan Intermediate 5 kahi mea nui i ka synthesis o Vorolazan, kahi papa o nā pūhui lāʻau ikaika i ʻike ʻia no kā lākou hopena therapeutic.He kuleana koʻikoʻi kēia waena i ka hana ʻana o Vorolazan, i hoʻohana ʻia i ka hoʻomohala ʻana i nā lāʻau lapaʻau like ʻole.
ʻO ka molecular structure o Vorolazan Intermediate 5 he hui 2-fluorophenyl i hoʻopili ʻia i ka moiety pyrrole-3-carboxaldehyde, hāʻawi iā ia i nā waiwai kemika kūʻokoʻa e waiwai nui ai i ka noiʻi lāʻau a me ka hoʻomohala ʻana.ʻO kāna ʻano hana i hoʻonohonoho pono ʻia e hiki ai ke hoʻololi a me ka hoʻololi ʻana, e lilo ia i mea koʻikoʻi i ka hana ʻana o Volorazan.
ʻO ka helu CAS 881674-56-2 he mea hōʻike kūʻokoʻa no kēia pūhui waena, e hōʻoia ana i kona hiki ʻana a me ka hōʻoia maikaʻi i nā noi lāʻau lapaʻau like ʻole.Mālama kēia i ka hilinaʻi a me ka kūlike o Vorolazan Intermediate 5 i ka noiʻi lāʻau lapaʻau, hoʻomohala a me ka hana ʻana.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.
![Tofacitinib Intermediate (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid a me (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No. 477600 -71-8](http://cdn.globalso.com/jdkhc/2R-3R-23-bis-4-methylbenzoyl-oxy-succinic-acid-and-3R-4R-N-4-dimethyl-1-phenylmethyl-3-piperidine-amine.jpg)
![10- (2-Chloropyrimidin-4-yl) -6,7,8,9-tetrahydropyridino [1,2-a] indole 2035090-53-8](http://cdn.globalso.com/jdkhc/10-2-Chloropyrimidin-4-yl-6789-tetrahydropyridino-12-a-indole.jpg)
![Vorolazan Intermediate 5 – (2-fluorophenyl) – 1 – [(pyridin-3-yl) sulfonyl] – 1H-pyrrol-3-formaldehyde CAS No. 881677-11-8](http://cdn.globalso.com/jdkhc/5-2-fluorophenyl-1-pyridin-3-yl-sulfonyl-1H-pyrrol-3-formaldehyde.jpg)
